FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes new compounds of the formula (I) where each of R1 and R2 means independently hydrogen atom or -CO(CR3R4)b(CR5R6)dCR7R8R9 where each of R3 and R4 means independently hydrogen atom, alkyl with 1-6 carbon atoms; each of R5 and R6 means independently hydrogen atom, alkyl with 1-6 carbon atoms or R5 and R6 can form in common the group X or cycloalkyl ring with 3-8 carbon atoms; R7 means hydrogen atom, alkyl with 1-6 carbon atoms; each of R8 and R9 means independently hydrogen atom, alkyl with 1-6 carbon atoms, -(CR3R4)fOR10 or R8 and R9 can in common form groups X or cycloalkyl ring with 3-8 carbon atoms; R10 means hydrogen atom, alkyl with 1-6 carbon atoms, tri (alkyl) with 1-6 carbon atoms silyl, tri (alkyl) with 1-6 carbon atoms silylethyl or tetrahydropyranyl; X means 5-[(2,2-di(alkyl] c 1-6 carbon atoms (1,3)-dioxanyl, 5-(2-spirocycloalkyl) with 3-8 carbon atoms (1,3)-dioxanyl, 4-[2,2-di(alkyl)] with 1-6 carbon atoms (1,3)-dioxanyl, 4-[2-spiro(cycloalkyl)] with 3-8 carbon atoms (1,3)-dioxanyl; b = 0-6; d = 0-6; f = 0-6 at condition that R1 and R2 are not hydrogen atom simultaneously and either R1 or R2 has at least one (CR3R4)fOR10, X or cycloalkyl with 3-8 carbon atoms. Pharmaceutically acceptable salt of this compound is used as an immunosuppressive, anti-inflammatory, antifungal, antiproliferative and antitumor agent. Invention describes also a method of synthesis of compounds of the formula (I) showing immunosuppressive activity and a method of treatment of patients using compounds of the formula (I). EFFECT: improved method of synthesis, enhanced effectiveness of compounds. 22 cl, 14 ex
Authors
Dates
1999-08-10—Published
1995-04-14—Filed